As AI reshapes biotechnology, stakeholders are acting to establish governance to maintain safety and efficacy standards.

A dozen prior leaders of the U.S. Food and Drug Administration — appointed by Republicans and Democrats alike — issued a scathing denunciation of new FDA assertions casting doubt ...